About Valirx
Valirx is a company based in London (United Kingdom) founded in 2000.. Valirx offers products and services including Drug Development Services and Therapeutic Pipelines. Valirx operates in a competitive market with competitors including GRAIL, Metabolon, Color, Maze Therapeutics and Alector, among others.
- Headquarter London, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Valirx Plc
-
Annual Revenue
$62.36 K (USD)418.49as on Dec 31, 2024
-
Net Profit
$-2.41 M (USD)5.99as on Dec 31, 2024
-
EBITDA
$-2.38 M (USD)6.94as on Dec 31, 2024
-
Latest Funding Round
$381.46 K (USD), Post-IPO
Jun 13, 2019
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Valirx
Valirx is a publicly listed company on the LSE with ticker symbol VAL in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Valirx
Valirx offers a comprehensive portfolio of products and services, including Drug Development Services and Therapeutic Pipelines. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers pipeline management for therapeutic areas and evaluations
Provides evaluation and development for various therapeutic applications
Unlock access to complete
Unlock access to complete
Leadership Team
2 people
Product Management Team
1 people
Operations Team
1 people
Finance and Accounting
1 people
Unlock access to complete
Funding Insights of Valirx
- Total Funding Total Funding
- Total Rounds 11
- Last Round Post-IPO — $381,458
-
First Round
First Round
(27 Dec 2013)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2019 | Amount | Post-IPO - Valirx | Valuation |
investors |
|
| Dec, 2018 | Amount | Post-IPO - Valirx | Valuation |
investors |
|
| Dec, 2018 | Amount | Post-IPO - Valirx | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Valirx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Valirx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Valirx Comparisons
Competitors of Valirx
Valirx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GRAIL, Metabolon, Color, Maze Therapeutics and Alector, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Solutions for biomarker discovery and diagnostic testing are provided.
|
|
| domain | founded_year | HQ Location |
Cancer care is delivered through a virtual clinic by Color.
|
|
| domain | founded_year | HQ Location |
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
|
|
| domain | founded_year | HQ Location |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
|
|
| domain | founded_year | HQ Location |
Proteomics platform developed for early cancer and neurological disease detection.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Valirx
Frequently Asked Questions about Valirx
When was Valirx founded?
Valirx was founded in 2000 and raised its 1st funding round 13 years after it was founded.
Where is Valirx located?
Valirx is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
What is the annual revenue of Valirx?
Annual revenue of Valirx is $62.36K as on Dec 31, 2024.
What does Valirx do?
Valirx was founded in 2000 and is based in London, United Kingdom. Operations center on the development of technologies and products for oncology therapeutics and diagnostics. Lead programs include VAL201, targeted at prostate cancer treatment, and VAL401, aimed at lung cancer. Proprietary assets encompass GeneICE (VAL101) for selective gene silencing, GeneICE Bcl-2 for targeting the Bcl-2 gene, and the NAV3 test for detecting malignancy onset.
Who are the top competitors of Valirx?
Valirx's top competitors include GRAIL, Alector and Maze Therapeutics.
What products or services does Valirx offer?
Valirx offers Drug Development Services and Therapeutic Pipelines.
Is Valirx publicly traded?
Yes, Valirx is publicly traded on LSE under the ticker symbol VAL.
What is Valirx's ticker symbol?
The ticker symbol of Valirx is VAL on LSE.